5 Health Care Provider Stocks to Buy Now

Advertisement

The grades of five health care provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

Cross Country Healthcare, Inc. (CCRN) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. For more information, get Portfolio Grader’s complete analysis of CCRN stock.

This is a strong week for Triple-S Management Corporation Class B (GTS). The company’s rating climbs to C from the previous week’s A. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) earns a B this week, jumping up from last week’s grade of C. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.

Bio-Reference Laboratories, Inc. (BRLI) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.

DaVita HealthCare Partners Inc. (DVA) improves from a C to a B rating this week. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/05/5-health-care-provider-stocks-to-buy-now-ccrn-gts-fms-15/.

©2024 InvestorPlace Media, LLC